David Denton, Pfizer
April 11, 2022 11:30 AM EDT
Pharma

Pfiz­er's Al­bert Bourla turns to an ac­com­plished deal­mak­er, strat­e­gy ex­pert for its next CFO

John Carroll

Editor & Founder

David Den­ton, who was dis­placed as CFO of CVS af­ter help­ing en­gi­neer the $69 bil­lion merg­er of his com­pa­ny with Aet­na, is jump­ing in­to the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Trump’s sci­ence crack­down hits rare dis­ease re­search: ‘We need to sit down with Elon Musk’

Ex­clu­sive: In­fec­tious dis­ease doc­tors con­sid­er 'mi­ni-ACIP' if RFK erodes CDC vac­cine pan­el

At least sev­en drug­mak­ers say they will par­tic­i­pate in round two of IRA ne­go­ti­a­tions 

Lil­ly joins mol­e­c­u­lar glue field with Mag­net deal worth up to $1.25B

Paci­ra ab­sorbs GQ Bio for $32M; Lay­offs at BMS, Ei­sai and CRISPR Ther­a­peu­tics

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times